Article Text

PDF
GW24-e0003 Effects of intensive atorvastatin on the expression of PDCD4 in CD4 + T lymphocytes from unstable angina patients during perioperative period of PCI
  1. Su Qiang,
  2. Li Lang,
  3. Liu Yang,
  4. Zhou You,
  5. Wang Jiang-you,
  6. Liu Tang-wei
  1. The First Affiliated Hospital of Guangxi Medical University

Abstract

Objectives To investigate the effects of intensive atorvastatin on the expression of PDCD4 in CD4 + T lymphocytes from unstable angina patients during perioperative period of PCI.

Methods A total of 66 unstable angina patients were enrolled. Unstable angina patients were randomized to pretreatment with intensive-dose atorvastatin (80mg/d, n = 33) or moderate-dose atorvastatin (20mg/d, n = 33). Circulating CD4 + T cells were obtained by magnetic cell sorting system (MACS) at baseline and post- PCI 18-24h. At the gene level, we used real-time fluorescent quantitative polymerase chain reaction (RFQ-PCR) to measure the levels of PDCD4 in CD4 + T lymphocyte. At the protein level, the expression of PDCD4 was detected with Western blot analysis. IL-10 and TNF-α were quantified by enzyme-linked immunosorbent assay (ELISA).

Results Compared with intensive-dose group before PCI, the expression of PDCD4 mRNA and protein levels dramatically decreased in intensive-dose group after PCI(P<0.05). 2) Compared with intensive-dose group and moderate-dose group before PCI, the serum level of TNF-α was increased in both groups after PCI. However, level of TNF-α in moderate-dose group was higher than intensive-dose group after PCI(P<0.05). 3) Compared with intensive-dose group and moderate-dose group before PCI, the serum level of IL-10 was increased in both groups after PCI. However, level of IL-10 in intensive-dose group was higher than moderate-dose group after PCI(P<0.05).

Conclusions Intensive-dose atorvastatin pretreatment reduced post-PCI myocardial inflammation through inhibiting the expression of PDCD4 in CD4+ T lymphocytes.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.